Clinical trial NCT01853202 - References

Cancer Thrombosis — EXercise Training for the Prevention of Cancer Thrombosis (EXPECT) Pilot Trial

Citation(s)

•   Agnelli G, George DJ, Kakkar AK, Fisher W, Lassen MR, Mismetti P, Mouret P, Chaudhari U, Lawson F, Turpie AG; SAVE-ONCO Investigators
  Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer. N Engl J Med. 2012 Feb 16;366(7):601-9. doi: 10.1056/NEJMoa1108898.
•   Akl EA, Vasireddi SR, Gunukula S, Yosuico VE, Barba M, Terrenato I, Sperati F, Schünemann H
  Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation. Cochrane Database Syst Rev. 2010 Dec 8;(12):CD006466. doi: 10.1002/14651858.CD006466.pub2. Review. Update in: Cochrane Database Syst Rev. 2011;(6):CD006466.
•   Ansell J
  Factor Xa or thrombin: is factor Xa a better target? J Thromb Haemost. 2007 Jul;5 Suppl 1:60-4. Review.
•   ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories
  ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002 Jul 1;166(1):111-7.
•   Ay C, Dunkler D, Simanek R, Thaler J, Koder S, Marosi C, Zielinski C, Pabinger I
  Prediction of venous thromboembolism in patients with cancer by measuring thrombin generation: results from the Vienna Cancer and Thrombosis Study. J Clin Oncol. 2011 May 20;29(15):2099-103. doi: 10.1200/JCO.2010.32.8294. Epub 2011 Apr 4.
•   Ay C, Haselböck J, Laczkovics C, Koder S, Pabinger I
  Thrombin generation in patients with a bleeding tendency of unknown origin. Ann Hematol. 2011 Sep;90(9):1099-104. doi: 10.1007/s00277-011-1201-8. Epub 2011 Feb 26.
•   Ay C, Vormittag R, Dunkler D, Simanek R, Chiriac AL, Drach J, Quehenberger P, Wagner O, Zielinski C, Pabinger I
  D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study. J Clin Oncol. 2009 Sep 1;27(25):4124-9. doi: 10.1200/JCO.2008.21.7752. Epub 2009 Jul 27.
•   Baglin T
  The measurement and application of thrombin generation. Br J Haematol. 2005 Sep;130(5):653-61. Review.
•   Brummel KE, Paradis SG, Butenas S, Mann KG
  Thrombin functions during tissue factor-induced blood coagulation. Blood. 2002 Jul 1;100(1):148-52.
•   Brummel-Ziedins K, Undas A, Orfeo T, Gissel M, Butenas S, Zmudka K, Mann KG
  Thrombin generation in acute coronary syndrome and stable coronary artery disease: dependence on plasma factor composition. J Thromb Haemost. 2008 Jan;6(1):104-10. Epub 2007 Oct 15.
•   Brummel-Ziedins K, Vossen CY, Rosendaal FR, Umezaki K, Mann KG
  The plasma hemostatic proteome: thrombin generation in healthy individuals. J Thromb Haemost. 2005 Jul;3(7):1472-81.
•   Brummel-Ziedins KE, Orfeo T, Gissel M, Mann KG, Rosendaal FR
  Factor Xa generation by computational modeling: an additional discriminator to thrombin generation evaluation. PLoS One. 2012;7(1):e29178. doi: 10.1371/journal.pone.0029178. Epub 2012 Jan 11.
•   Butenas S, Mann KG
  Blood coagulation. Biochemistry (Mosc). 2002 Jan;67(1):3-12. Review.
•   Butenas S, Orfeo T, Gissel MT, Brummel KE, Mann KG
  The significance of circulating factor IXa in blood. J Biol Chem. 2004 May 28;279(22):22875-82. Epub 2004 Mar 23.
•   Butenas S, van 't Veer C, Mann KG
  Evaluation of the initiation phase of blood coagulation using ultrasensitive assays for serine proteases. J Biol Chem. 1997 Aug 22;272(34):21527-33.
•   Caine GJ, Stonelake PS, Lip GY, Kehoe ST
  The hypercoagulable state of malignancy: pathogenesis and current debate. Neoplasia. 2002 Nov-Dec;4(6):465-73. Review.
•   Chew HK, Wun T, Harvey D, Zhou H, White RH
  Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med. 2006 Feb 27;166(4):458-64.
•   Connolly GC, Khorana AA
  Risk stratification for cancer-associated venous thromboembolism. Best Pract Res Clin Haematol. 2009 Mar;22(1):35-47. doi: 10.1016/j.beha.2008.12.006. Review.
•   Cushman M, Cornell ES, Howard PR, Bovill EG, Tracy RP
  Laboratory methods and quality assurance in the Cardiovascular Health Study. Clin Chem. 1995 Feb;41(2):264-70.
•   Evenson KR, Stevens J, Thomas R, Cai J
  Effect of cardiorespiratory fitness on mortality among hypertensive and normotensive women and men. Epidemiology. 2004 Sep;15(5):565-72.
•   Flinterman LE, van Hylckama Vlieg A, Cannegieter SC, Rosendaal FR
  Long-term survival in a large cohort of patients with venous thrombosis: incidence and predictors. PLoS Med. 2012 Jan;9(1):e1001155. doi: 10.1371/journal.pmed.1001155. Epub 2012 Jan 10.
•   Galvão DA, Newton RU
  Review of exercise intervention studies in cancer patients. J Clin Oncol. 2005 Feb 1;23(4):899-909. Review.
•   Gissel M, Undas A, Slowik A, Mann KG, Brummel-Ziedins KE
  Plasma factor and inhibitor composition contributes to thrombin generation dynamics in patients with acute or previous cerebrovascular events. Thromb Res. 2010 Oct;126(4):262-9. doi: 10.1016/j.thromres.2010.07.002. Epub 2010 Aug 14.
•   Goldenberg N, Kahn SR, Solymoss S
  Markers of coagulation and angiogenesis in cancer-associated venous thromboembolism. J Clin Oncol. 2003 Nov 15;21(22):4194-9.
•   Gómez-Outes A, Terleira-Fernández AI, Suárez-Gea ML, Vargas-Castrillón E
  Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons. BMJ. 2012 Jun 14;344:e3675. doi: 10.1136/bmj.e3675. Review.
•   Hann DM, Jacobsen PB, Azzarello LM, Martin SC, Curran SL, Fields KK, Greenberg H, Lyman G
  Measurement of fatigue in cancer patients: development and validation of the Fatigue Symptom Inventory. Qual Life Res. 1998 May;7(4):301-10.
•   Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ 3rd
  Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med. 2000 Mar 27;160(6):809-15.
•   Hockin MF, Jones KC, Everse SJ, Mann KG
  A model for the stoichiometric regulation of blood coagulation. J Biol Chem. 2002 May 24;277(21):18322-33. Epub 2002 Mar 13.
•   Jones LW, Courneya KS, Mackey JR, Muss HB, Pituskin EN, Scott JM, Hornsby WE, Coan AD, Herndon JE 2nd, Douglas PS, Haykowsky M
  Cardiopulmonary function and age-related decline across the breast cancer survivorship continuum. J Clin Oncol. 2012 Jul 10;30(20):2530-7. doi: 10.1200/JCO.2011.39.9014. Epub 2012 May 21.
•   Jones LW, Eves ND, Haykowsky M, Joy AA, Douglas PS
  Cardiorespiratory exercise testing in clinical oncology research: systematic review and practice recommendations. Lancet Oncol. 2008 Aug;9(8):757-65. doi: 10.1016/S1470-2045(08)70195-5. Review.
•   Jones LW, Eves ND, Mackey JR, Peddle CJ, Haykowsky M, Joy AA, Courneya KS, Tankel K, Spratlin J, Reiman T
  Safety and feasibility of cardiopulmonary exercise testing in patients with advanced cancer. Lung Cancer. 2007 Feb;55(2):225-32. Epub 2006 Nov 17.
•   Jones LW, Eves ND, Peterson BL, Garst J, Crawford J, West MJ, Mabe S, Harpole D, Kraus WE, Douglas PS
  Safety and feasibility of aerobic training on cardiopulmonary function and quality of life in postsurgical nonsmall cell lung cancer patients: a pilot study. Cancer. 2008 Dec 15;113(12):3430-9. doi: 10.1002/cncr.23967.
•   Kahn SR, Lim W, Dunn AS, Cushman M, Dentali F, Akl EA, Cook DJ, Balekian AA, Klein RC, Le H, Schulman S, Murad MH; American College of Chest Physicians
  Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb;141(2 Suppl):e195S-226S. doi: 10.1378/chest.11-2296.
•   Khorana AA, Dalal M, Lin J, Connolly GC
  Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States. Cancer. 2013 Feb 1;119(3):648-55. doi: 10.1002/cncr.27772. Epub 2012 Aug 14.
•   Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH
  Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost. 2007 Mar;5(3):632-4.
•   Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW
  Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood. 2008 May 15;111(10):4902-7. doi: 10.1182/blood-2007-10-116327. Epub 2008 Jan 23.
•   Knols R, Aaronson NK, Uebelhart D, Fransen J, Aufdemkampe G
  Physical exercise in cancer patients during and after medical treatment: a systematic review of randomized and controlled clinical trials. J Clin Oncol. 2005 Jun 1;23(16):3830-42. Review.
•   Lee KW, Lip GY
  Effects of lifestyle on hemostasis, fibrinolysis, and platelet reactivity: a systematic review. Arch Intern Med. 2003 Oct 27;163(19):2368-92. Review.
•   Levitan N, Dowlati A, Remick SC, Tahsildar HI, Sivinski LD, Beyth R, Rimm AA
  Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data. Medicine (Baltimore). 1999 Sep;78(5):285-91.
•   Lindqvist PG, Epstein E, Olsson H
  The relationship between lifestyle factors and venous thromboembolism among women: a report from the MISS study. Br J Haematol. 2009 Jan;144(2):234-40. doi: 10.1111/j.1365-2141.2008.07460.x. Epub 2008 Nov 19.
•   Lockard MM, Gopinathannair R, Paton CM, Phares DA, Hagberg JM
  Exercise training-induced changes in coagulation factors in older adults. Med Sci Sports Exerc. 2007 Apr;39(4):587-92.
•   Lyman GH, Khorana AA, Falanga A, Clarke-Pearson D, Flowers C, Jahanzeb M, Kakkar A, Kuderer NM, Levine MN, Liebman H, Mendelson D, Raskob G, Somerfield MR, Thodiyil P, Trent D, Francis CW; American Society of Clinical Oncology
  American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. J Clin Oncol. 2007 Dec 1;25(34):5490-505. Epub 2007 Oct 29. Review.
•   Marcus BH, Selby VC, Niaura RS, Rossi JS
  Self-efficacy and the stages of exercise behavior change. Res Q Exerc Sport. 1992 Mar;63(1):60-6.
•   Nalluri SR, Chu D, Keresztes R, Zhu X, Wu S
  Risk of venous thromboembolism with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis. JAMA. 2008 Nov 19;300(19):2277-85. doi: 10.1001/jama.2008.656. Review.
•   Patnaik JL, Byers T, Diguiseppi C, Denberg TD, Dabelea D
  The influence of comorbidities on overall survival among older women diagnosed with breast cancer. J Natl Cancer Inst. 2011 Jul 20;103(14):1101-11. doi: 10.1093/jnci/djr188. Epub 2011 Jun 30.
•   Patnaik SK, Kannisto E, Mallick R, Yendamuri S
  Overexpression of the lung cancer-prognostic miR-146b microRNAs has a minimal and negative effect on the malignant phenotype of A549 lung cancer cells. PLoS One. 2011;6(7):e22379. doi: 10.1371/journal.pone.0022379. Epub 2011 Jul 18.
•   Poerwanto S, Stevenson M, de Klerk N
  Infant mortality and family welfare: policy implications for Indonesia. J Epidemiol Community Health. 2003 Jul;57(7):493-8.
•   Rauramaa R, Li G, Väisänen SB
  Dose-response and coagulation and hemostatic factors. Med Sci Sports Exerc. 2001 Jun;33(6 Suppl):S516-20; discussion S528-9. Review.
•   Rickles FR, Falanga A
  Molecular basis for the relationship between thrombosis and cancer. Thromb Res. 2001 Jun 15;102(6):V215-24. Review.
•   Rickles FR, Patierno S, Fernandez PM
  Tissue factor, thrombin, and cancer. Chest. 2003 Sep;124(3 Suppl):58S-68S. Review.
•   Schmitz KH, Courneya KS, Matthews C, Demark-Wahnefried W, Galvão DA, Pinto BM, Irwin ML, Wolin KY, Segal RJ, Lucia A, Schneider CM, von Gruenigen VE, Schwartz AL; American College of Sports Medicine
  American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc. 2010 Jul;42(7):1409-26. doi: 10.1249/MSS.0b013e3181e0c112. Erratum in: Med Sci Sports Exerc. 2011 Jan;43(1):195.
•   Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ 3rd
  Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med. 1998 Mar 23;158(6):585-93.
•   Sørensen HT, Mellemkjaer L, Olsen JH, Baron JA
  Prognosis of cancers associated with venous thromboembolism. N Engl J Med. 2000 Dec 21;343(25):1846-50.
•   Spitzer RL, Kroenke K, Williams JB, Löwe B
  A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006 May 22;166(10):1092-7.
•   van Stralen KJ, Le Cessie S, Rosendaal FR, Doggen CJ
  Regular sports activities decrease the risk of venous thrombosis. J Thromb Haemost. 2007 Nov;5(11):2186-92. Epub 2007 Aug 14.
•   Wang JS, Li YS, Chen JC, Chen YW
  Effects of exercise training and deconditioning on platelet aggregation induced by alternating shear stress in men. Arterioscler Thromb Vasc Biol. 2005 Feb;25(2):454-60. Epub 2004 Nov 29.
•   Wang JS
  Exercise prescription and thrombogenesis. J Biomed Sci. 2006 Nov;13(6):753-61. Epub 2006 Aug 24. Review.
•   Wang T, Nelson RA, Bogardus A, Grannis FW Jr
  Five-year lung cancer survival: which advanced stage nonsmall cell lung cancer patients attain long-term survival? Cancer. 2010 Mar 15;116(6):1518-25. doi: 10.1002/cncr.24871.
•   Wannamethee SG, Lowe GD, Whincup PH, Rumley A, Walker M, Lennon L
  Physical activity and hemostatic and inflammatory variables in elderly men. Circulation. 2002 Apr 16;105(15):1785-90.
•   Ware JE Jr, Sherbourne CD
  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992 Jun;30(6):473-83.
•   Wei S, Pan Z, Siegal GP, Winokur TS, Carroll AJ, Jhala D
  Complex analysis of a recurrent pleomorphic hyalinizing angiectatic tumor of soft parts. Hum Pathol. 2012 Jan;43(1):121-6. doi: 10.1016/j.humpath.2011.02.023. Epub 2011 Jul 5.
•   Zwicker JI, Furie BC, Furie B
  Cancer-associated thrombosis. Crit Rev Oncol Hematol. 2007 May;62(2):126-36. Epub 2007 Feb 12. Review.

EXercise Training for the Prevention of Cancer Thrombosis (EXPECT) Pilot Trial

Details for clinical trial NCT01853202